Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2019-2025

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2018, the global Viral Vectors and Plasmid DNA Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Viral Vectors and Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vectors and Plasmid DNA Manufacturing development in United States, Europe and China.

The key players covered in this study
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory

Market segment by Type, the product can be split into
Plasmid DNA
Viral Vectors

Market segment by Application, split into
Cancers
Inherited Disorders
Viral Infections
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Viral Vectors and Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players.
To present the Viral Vectors and Plasmid DNA Manufacturing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Viral Vectors and Plasmid DNA Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports